SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-080226
Filing Date
2014-03-03
Accepted
2014-03-03 16:21:04
Documents
3
Period of Report
2014-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d687604d8k.htm 8-K 14217
2 EX-99.1 d687604dex991.htm EX-99.1 116330
3 GRAPHIC g687604g93o81.jpg GRAPHIC 8249
  Complete submission text file 0001193125-14-080226.txt   143315
Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024
Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500
PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)

IRS No.: 770683487 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35703 | Film No.: 14660568
SIC: 2834 Pharmaceutical Preparations